SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
- PMID: 35843590
- PMCID: PMC9288264
- DOI: 10.1016/j.arr.2022.101687
SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations
Abstract
Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to impact our lives by causing widespread illness and death and poses a threat due to the possibility of emerging strains. SARS-CoV-2 targets angiotensin-converting enzyme 2 (ACE2) before entering vital organs of the body, including the brain. Studies have shown systemic inflammation, cellular senescence, and viral toxicity-mediated multi-organ failure occur during infectious periods. However, prognostic investigations suggest that both acute and long-term neurological complications, including predisposition to irreversible neurodegenerative diseases, can be a serious concern for COVID-19 survivors, especially the elderly population. As emerging studies reveal sites of SARS-CoV-2 infection in different parts of the brain, potential causes of chronic lesions including cerebral and deep-brain microbleeds and the likelihood of developing stroke-like pathologies increases, with critical long-term consequences, particularly for individuals with neuropathological and/or age-associated comorbid conditions. Our recent studies linking the blood degradation products to genome instability, leading to cellular senescence and ferroptosis, raise the possibility of similar neurovascular events as a result of SARS-CoV-2 infection. In this review, we discuss the neuropathological consequences of SARS-CoV-2 infection in COVID survivors, focusing on possible hemorrhagic damage in brain cells, its association to aging, and the future directions in developing mechanism-guided therapeutic strategies.
Keywords: Brain fog; COVID-19; Coronavirus; Ferroptosis; Genome instability; Hemorrhage; SARS-CoV-2; Senescence.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.J Mol Neurosci. 2021 Nov;71(11):2192-2209. doi: 10.1007/s12031-020-01767-6. Epub 2021 Jan 19. J Mol Neurosci. 2021. PMID: 33464535 Free PMC article. Review.
-
Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941. Epub 2020 May 12. J Stroke Cerebrovasc Dis. 2020. PMID: 32689643 Free PMC article. Review.
-
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16. Rev Neurol (Paris). 2021. PMID: 33446327 Free PMC article. Review.
-
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28. Neurol Sci. 2020. PMID: 32725449 Free PMC article. Review.
-
Emerging neurotropic features of SARS-CoV-2.J Mol Cell Biol. 2021 Dec 30;13(10):705-711. doi: 10.1093/jmcb/mjab044. J Mol Cell Biol. 2021. PMID: 34289037 Free PMC article. Review.
Cited by
-
Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer's disease.Transl Psychiatry. 2023 Dec 16;13(1):396. doi: 10.1038/s41398-023-02692-z. Transl Psychiatry. 2023. PMID: 38104129 Free PMC article.
-
Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC).Biomedicines. 2023 Jan 27;11(2):377. doi: 10.3390/biomedicines11020377. Biomedicines. 2023. PMID: 36830913 Free PMC article. Review.
-
Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review.J Neuroinflammation. 2024 Jun 6;21(1):152. doi: 10.1186/s12974-024-03139-y. J Neuroinflammation. 2024. PMID: 38845026 Free PMC article. Review.
-
SARS-CoV-2-Induced Amyloidgenesis: Not One, but Three Hypotheses for Cerebral COVID-19 Outcomes.Metabolites. 2022 Nov 11;12(11):1099. doi: 10.3390/metabo12111099. Metabolites. 2022. PMID: 36422238 Free PMC article.
-
The role of cell death in SARS-CoV-2 infection.Signal Transduct Target Ther. 2023 Sep 20;8(1):357. doi: 10.1038/s41392-023-01580-8. Signal Transduct Target Ther. 2023. PMID: 37726282 Free PMC article. Review.
References
-
- Ahn J.H., Kim J., Hong S.P., Choi S.Y., Yang M.J., Ju Y.S., Kim Y.T., Kim H.M., Rahman M.D.T., Chung M.K., Hong S.D., Bae H., Lee C.S., Koh G.Y. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Investig. 2021;131(13) doi: 10.1172/jci148517. - DOI - PMC - PubMed
-
- Ahn M., Anderson D.E., Zhang Q., Tan C.W., Lim B.L., Luko K., Wen M., Chia W.N., Mani S., Wang L.C., Ng J.H.J., Sobota R.M., Dutertre C.A., Ginhoux F., Shi Z.L., Irving A.T., Wang L.F. Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host. Nat. Microbiol. 2019;4(5):789–799. doi: 10.1038/s41564-019-0371-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous